
Science Resources RSS Feeds
|
 |
 |
 |
Pulmonary Fibrosis Current Events | Pulmonary Fibrosis News
|
| Page
1 of
22 |
429 Results |
|
|
|
Sort By:
Page Views | Date |
Viagra for alleviation of pulmonary hypertension? Results of a preliminary study in this week's issue of THE LANCET suggest that Viagra may have a future role in the treatment of pulmonary hypertension (increased blood pressure in the pulmonary artery), a severe and potentially fatal condition causing respiratory impairment. Lung fibrosis (scarring of the lungs due to inflammation of the... view more... (2002-09-18)
Preventing lung scarring may extend lives of lung cancer patients Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life. view more (2007-10-30)
Against pulmonary fibrosis The biotech companies Digna Biotech and Biotherapix have signed an agreement to jointly apply their patented products towards the development of a treatment for pulmonary fibrosis. view more (2006-03-06)
Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease typically characterized by the slow but progressive onset of shortness of breath or cough. view more (2007-05-31)
Extra-aggressive form of idiopathic pulmonary fibrosis identified Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly. view more (2007-05-30)
Translational research patented first experimental treatment against idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis is a disease with unknown cause with a very severe prognosis; when detected, it is already in an advanced stage. view more (2007-12-26)
A candidate gene for familial idiopathic pulmonary fibrosis identified ELMOD2-gene is a prime candidate gene for familial idiopathic pulmonary fibrosis, suggests the recent study published by the researchers at the University and University Hospital of Helsinki, Finland. view more (2006-06-29)
New clinical guidelines for exacerbations in cystic fibrosis The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices. view more (2009-10-23)
Molecular pathway appears crucial in development of pulmonary fibrosis A study led by Massachusetts General Hospital (MGH) researchers may have found a key mechanism underlying idiopathic pulmonary fibrosis (IPF), a usually fatal lung disease for which transplantation is the only successful treatment. view more (2007-12-13)
Inheritance, Smoking Spawn Mysterious and Deadly Lung Disease An incurable, deadly lung disorder, "idiopathic interstitial pneumonia" (IIP), whose causes were mysterious arises from a combination of a genetic predisposition and damage due to inhaled chemicals, notably from cigarette smoking. view more (2005-09-28)
First different black/white mechanism in pulmonary fibrosis/scleroderma identified Of the more than 40,000 persons who die each year in the U.S. from pulmonary fibrosis, the mortality rate among African-Americans is twice as high Caucasians. view more (2006-04-05)
Common antibacterial treatment linked to sensorineural hearing loss in cystic fibrosis patients An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery. view more (2009-07-01)
The natural history of 'healthy-HCV carriers' A normal liver is observed in about 10% of HCV infected patients and the natural history of theses so-called "healthy-HCV carriers" is not fully defined. view more (2008-09-24)
Cystic fibrosis testing -- next steps Three reports describing advances in cystic fibrosis genetic testing appear in the May 2009 issue of The Journal of Molecular Diagnostics. view more (2009-04-28)
Antifibrotic effects of green tea Several studies have shown that lipid peroxidation stimulates collagen production in fibroblasts and hepatic stellate cells (HSC), and plays an important role in the development of liver fibrosis. view more (2009-11-18)
Rare Lung Disease Cells Indicate Higher Death Risk Large numbers of certain cells in the lungs of patients diagnosed with idiopathic pulmonary fibrosis may increase their chance of death, UC researchers have discovered. view more (2008-01-17)
Sodium channel blocker shows promise as a potential treatment for cystic fibrosis Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to researchers at Parion Sciences in Durham, N.C. view more (2009-05-18)
Advanced genomics and proteomics improve the diagnosis and treatment of a deadly lung disease In an article in the Jan. 15 issue of the American Journal of Respiratory Critical Care Medicine, University of Pittsburgh researchers report that a serious, life-threatening form of pulmonary fibrosis, called idiopathic pulmonary fibrosis, lacks all the hallmarks of inflammation and is probably unnecessarily treated with anti-inflammatory drugs. view more (2006-01-12)
Biomarkers identified for idiopathic pulmonary fibrosis The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public... view more... (2008-04-29)
Antibiotic Could Offer Promise For Treatment Of Cystic Fibrosis The antibiotic azithromycin could offer some benefit to people with cystic fibrosis if they do not respond to conventional treatment, suggest authors of a study in this week's issue of THE LANCET. Cystic fibrosis is a severe genetic disorder-the most commonly recessively inherited disorder in white populations. Treatment is limited, and aimed at... view more... (2002-09-25)
| |
| Page
1 of
22 |
429 Results |
|
|
|
Sort By:
Page Views | Date |
|
|